Advertisement
Advertisement
BHVN
Biohaven Ltd.
14.66
USDSponsored
+0.24
+1.66%
Aug 07, 15:59 UTC -4
Closed
After-Market
14.54
-0.12
-0.81%
BHVN Earnings Reports
Positive Surprise Ratio
BHVN beat 5 of 15 last estimates.
33%
Next Report
Date of Next Report
Nov 09, 2026
Estimate for Q3 26 (Revenue/ EPS)
$818.78K
/-$0.69
Implied change from Q2 26 (Revenue/ EPS)
--
/--
Implied change from Q3 25 (Revenue/ EPS)
--
/-57.93%
Biohaven Ltd. earnings per share and revenue
On Aug 03, 2026, BHVN reported earnings of -- USD per share (EPS) for Q2 26, -- the estimate of -0.74 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 546.17 thousand, with a --% difference.
Looking ahead to Q3 26, 11 analysts forecast an EPS of -0.69 USD, with revenue projected to reach 818.78 thousand USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
BioMarin Pharmaceuticals Inc
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.70
Actual
$1.20
Surprise
+71.04%
ANI Pharmaceuticals, Inc.
Report Date
Aug 07, 2026 For Q2 26
Estimate
$2.09
Actual
$2.21
Surprise
+5.69%
Monte Rosa Therapeutics, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.39
Actual
-$0.43
Surprise
-9.58%
CytomX Therapeutics, Inc.
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.07
Actual
-$0.09
Surprise
-13.78%
Prime Medicine, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.26
Actual
-$0.24
Surprise
+8.57%
Prothena Corporation plc Ordinary Shares
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.39
Actual
-$0.32
Surprise
+19.76%
Ocugen, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.05
Actual
-$0.07
Surprise
-26.35%
X4 Pharmaceuticals, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.18
Actual
-$0.13
Surprise
+29.19%
Cellectis S.A. - ADR
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.27
Actual
-$0.22
Surprise
+20.89%
Entera Bio Ltd. Ordinary Shares
Report Date
Aug 07, 2026 For Q2 26
Estimate
-$0.08
Actual
-$0.14
Surprise
-71.57%
FAQ
What were Biohaven Ltd.'s earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Biohaven Ltd. reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to Biohaven Ltd.'s Q2 2026 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Biohaven Ltd. expected to report next?
The next earning report is scheduled for Nov 09, 2026.
What are the forecasts for Biohaven Ltd.'s next earnings report?
Based on 11
analysts, Biohaven Ltd. is expected to report EPS of -$0.69 and revenue of $818.78K for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement